Cargando…

Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer’s disease

Subjective cognitive decline (SCD) is regarded as the first clinical manifestation in the Alzheimer’s disease (AD) continuum. Investigating populations with SCD is important for understanding the early pathological mechanisms of AD and identifying SCD-related biomarkers, which are critical for the e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Xiaoqi, Huang, Weijie, Su, Li, Xing, Yue, Jessen, Frank, Sun, Yu, Shu, Ni, Han, Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7507636/ https://www.ncbi.nlm.nih.gov/pubmed/32962744 http://dx.doi.org/10.1186/s13024-020-00395-3

Ejemplares similares

Progress in blood biomarkers of subjective cognitive decline in preclinical Alzheimer's disease
por: Yu, Xianfeng, et al.
Publicado: (2023)

Subjective Cognitive Decline
por: Tales, Andrea, et al.
Publicado: (2015)

The preservation of right cingulum fibers in subjective cognitive decline of preclinical phase of Alzheimer’s disease
por: Sun, Yu, et al.
Publicado: (2023)

Prediction of Alzheimer's Pathological Changes in Subjective Cognitive Decline Using the Self-report Questionnaire and Neuroimaging Biomarkers
por: Hong, Yun Jeong, et al.
Publicado: (2019)

Subjective Cognitive Decline as a Preclinical Marker for Alzheimer's Disease: The Challenge of Stability Over Time
por: Ávila-Villanueva, Marina, et al.
Publicado: (2017)

Longitudinal evaluation of criteria for subjective cognitive decline and preclinical Alzheimer's disease in a memory clinic sample
por: Eckerström, Marie, et al.
Publicado: (2017)

Clinical and cognitive characteristics of preclinical Alzheimer's disease in the Japanese Alzheimer's Disease Neuroimaging Initiative cohort
por: Ihara, Ryoko, et al.
Publicado: (2018)

Editorial: Exploring Reliable Markers and Prediction Indexes for the Progression From Subjective Cognitive Decline to Cognitive Impairment
por: Jiang, Jiehui, et al.
Publicado: (2021)

Subjective cognitive decline and rates of incident Alzheimer’s disease and non-Alzheimer’s disease dementia
por: Slot, Rosalinde E. R., et al.
Publicado: (2018)

Functional neuroimaging in subjective cognitive decline: current status and a research path forward
por: Viviano, Raymond P., et al.
Publicado: (2020)

Cognitive and neuroimaging markers for preclinical vascular cognitive impairment
por: Lowry, Ellen, et al.
Publicado: (2021)

Cognitive Decline in Preclinical Alzheimer’s Disease: Amyloid-Beta versus Tauopathy
por: Huber, Colin M., et al.
Publicado: (2017)

Editorial: Exploring reliable markers and prediction indexes for the progression from subjective cognitive decline to cognitive impairment, volume II
por: Jessen, Frank, et al.
Publicado: (2023)

Subjective Cognitive Decline and Alzheimer's Disease Spectrum Disorder
por: Hong, Yun Jeong, et al.
Publicado: (2017)

Prediction of Longitudinal Cognitive Decline in Preclinical Alzheimer Disease Using Plasma Biomarkers
por: Mattsson-Carlgren, Niklas, et al.
Publicado: (2023)

Interactions Between Neuropsychiatric Symptoms and Alzheimer's Disease Neuroimaging Biomarkers in Predicting Longitudinal Cognitive Decline
por: Pink, Anna, et al.
Publicado: (2023)

Neural correlates and predictors of subjective cognitive decline in patients with Parkinson’s disease
por: Ophey, Anja, et al.
Publicado: (2021)

Subjective cognitive decline: The first clinical manifestation of Alzheimer's disease?
por: Studart, Adalberto, et al.
Publicado: (2016)

Electroencephalography for Early Detection of Alzheimer’s Disease in Subjective Cognitive Decline
por: Shim, YongSoo, et al.
Publicado: (2022)

Subjective Cognitive Decline and Related Cognitive Deficits
por: Si, Tong, et al.
Publicado: (2020)

The Alzheimer’s Prevention Initiative Composite Cognitive Test: a practical measure for tracking cognitive decline in preclinical Alzheimer’s disease
por: Langbaum, Jessica B., et al.
Publicado: (2020)

Subregional volume reduction of the cholinergic forebrain in subjective cognitive decline (SCD)
por: Scheef, Lukas, et al.
Publicado: (2018)

Preclinical Alzheimer's disease and longitudinal driving decline
por: Roe, Catherine M., et al.
Publicado: (2016)

Structural Neuroimaging Markers of Cognitive Decline in Parkinson's Disease
por: Hanganu, Alexandru, et al.
Publicado: (2016)

Combined Support Vector Machine Classifier and Brain Structural Network Features for the Individual Classification of Amnestic Mild Cognitive Impairment and Subjective Cognitive Decline Patients
por: Huang, Weijie, et al.
Publicado: (2021)

Identification of prognostic factors to predict cognitive decline of patients with early Alzheimer's disease in the Japanese Alzheimer's Disease Neuroimaging Initiative study
por: Yagi, Takuya, et al.
Publicado: (2019)

Subjective cognitive decline: opposite links to neurodegeneration across the Alzheimer’s continuum
por: Kuhn, Elizabeth, et al.
Publicado: (2021)

Abnormal Dynamic Functional Networks in Subjective Cognitive Decline and Alzheimer's Disease
por: Wang, Jue, et al.
Publicado: (2022)

Differences regarding the five-factor personality model in patients with subjective cognitive decline and mild cognitive impairment
por: Berger-Sieczkowski, Evelyn, et al.
Publicado: (2018)

Visuoconstructional Abilities of Patients With Subjective Cognitive Decline, Mild Cognitive Impairment and Alzheimer’s Disease
por: Knechtl, Paula, et al.
Publicado: (2023)

Consequences of redefining Alzheimer's disease in terms of amyloid burden without regard to cognitive decline
por: Robinson, Stephen R., et al.
Publicado: (2018)

Cognitive performance before and after the onset of subjective cognitive decline in old age
por: Koppara, Alexander, et al.
Publicado: (2015)

Determining clinically meaningful decline in preclinical Alzheimer disease
por: Insel, Philip S., et al.
Publicado: (2019)

Association between NME8 Locus Polymorphism and Cognitive Decline, Cerebrospinal Fluid and Neuroimaging Biomarkers in Alzheimer's Disease
por: Liu, Ying, et al.
Publicado: (2014)

Lower Body Mass Index at Baseline Is Related to Steeper Cognitive Decline in the Alzheimer’s Disease Neuroimaging Initiative Cohort
por: Haley, Andreana P., et al.
Publicado: (2023)

Reduced future-oriented decision making in individuals with subjective cognitive decline: A functional MRI study
por: Hu, Xiaochen, et al.
Publicado: (2017)

APOE and BDNF polymorphisms moderate amyloid β-related cognitive decline in preclinical Alzheimer's disease
por: Lim, Y Y, et al.
Publicado: (2015)

Cognitive and Neuroimaging Profiles of Individuals With Dual Decline in Memory and Gait
por: Tian, Qu, et al.
Publicado: (2020)

The neuroimaging of neurodegenerative and vascular disease in the secondary prevention of cognitive decline
por: Schaeffer, Morgan J., et al.
Publicado: (2021)

Current advances in digital cognitive assessment for preclinical Alzheimer's disease
por: Öhman, Fredrik, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_spdb66pgcqu9mboemit96i2g1a